Name: Pharmacogenomics Panel
SKU: 132
Availability: InStock

Description

Mobile Drug & DNA has streamlined the DNA test process:

Order your test online.
Complete payment.
As part of our process, we require that you consult with a genetic counsellor both before and after undergoing the test. Mobile Drug & DNA will facilitate this by requesting a referral form to be completed by your GP, genetic counselor, or specialist.
When you order the Pharmacogenomics Panel, we will provide you with the necessary referral forms for your genetic counsellor or doctor to fill out. Subsequently, we will arrange for your sample collection kit to be sent directly to one of our affiliated pathology centers and schedule your appointment for sample collection.
Following the analysis, your results will be sent to your genetic counsellor or doctor. They will then thoroughly discuss the results with you, ensuring you receive the best and most accurate information tailored to your individual test. You can expect to receive your results within 2-3 weeks.

About The Test

As each individual possesses a unique genetic makeup, their response to medications can vary significantly. What works effectively for one person may not be suitable or may even induce adverse reactions in another. Pharmacogenomics (PGx) testing offers a personalised approach to medicine by analysing an individual’s genetic profile to determine the most suitable drugs and dosages while minimising potential side effects.

PGx testing is beneficial for individuals currently using or planning to use medications for covered conditions. It can also be valuable for those who have tried multiple medications without success in treating their symptoms.

In psychiatry, where antidepressants play a crucial role, PGx testing is particularly relevant. With around 30-50% of patients failing to respond to initial antidepressant treatment, genetically guided prescribing can enhance the likelihood of finding an effective treatment type and dosage, potentially leading to greater remission rates.

Additionally, our PGx panel includes coverage of over 60 common oncology drugs. For cancer patients, PGx testing can help identify effective treatment options before commencing therapy or provide insights into why current medications may not be working effectively during treatment.

Advantages

Our Pharmacogenomics Panel offers several benefits:

Minimising the “trial and error” approach: By analysing genetic data, we can tailor therapy and dosages to an individual.
Reducing adverse reactions: Understanding how genes influence drug metabolism helps identify medications that may cause adverse reactions in patients.
Saving time and money: By selecting medications based on genetic profiles, patients can avoid costly and ineffective drugs.
Reducing duration of medication use: Personalised medication plans derived from genetic analysis can lead to more effective treatment outcomes.

Panels

Our Pharmacogenomics Panel utilises next-generation sequencing to analyse genes associated with 40 known drug-metabolising enzymes (DMEs). These genes include:

ABCB1, ABCG2, ADRA2A, ANKK1, APOE, COMT, CYP1A2, CYP2B6, CYP2C19, CYP2C8, CYP2C9, CYP2D6, CYP3A4, CYP3A5, DBH, DPYD, DRD1, DRD4, F2, F5, GABRA6, GABRP, GRIK4, HLA-A*3101, HLAB*1502, HLA-B*5701, HTR2A, HTR2C, ITGB3, KIF6, MTHFR, OPRD1, OPRK1, OPRM1, SLCO1B1, TPMT, UGT1A1, UGT2B15, UGT2B7 and VKORC1.

We offer 12 Pharmacogenomics (PGx) panels, and the initial cost covers 2 tests. Additional tests can be purchased upon arrangement.